tenk.fyi

MYRIAD GENETICS INC

MYGNNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$824.5M

1.6% YoY

Net Income

-$365.9M

187.4% YoY

EPS

$-3.95

180.1% YoY

Cash

$149.6M

46.1% YoY

FY 2025 · As of 2025-12-31